BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25450612)

  • 21. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.
    Silvestre JS; Tamarat R; Senbonmatsu T; Icchiki T; Ebrahimian T; Iglarz M; Besnard S; Duriez M; Inagami T; Lévy BI
    Circ Res; 2002 May; 90(10):1072-9. PubMed ID: 12039796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesis.
    Tepeköylü C; Wang FS; Kozaryn R; Albrecht-Schgoer K; Theurl M; Schaden W; Ke HJ; Yang Y; Kirchmair R; Grimm M; Wang CJ; Holfeld J
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):971-8. PubMed ID: 23395097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
    Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
    J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. God gives IL-19 with both hands: anti-inflammatory but pro-angiogenic.
    Yan X; Sano M
    J Mol Cell Cardiol; 2015 Mar; 80():20-2. PubMed ID: 25533938
    [No Abstract]   [Full Text] [Related]  

  • 25. BubR1 insufficiency impairs angiogenesis in aging and in experimental critical limb ischemic mice.
    Okadome J; Matsumoto T; Yoshiya K; Matsuda D; Tamada K; Onimaru M; Nakano K; Egashira K; Yonemitsu Y; Maehara Y
    J Vasc Surg; 2018 Aug; 68(2):576-586.e1. PubMed ID: 28974341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia.
    Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N
    Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization.
    Zhu Y; Tan W; Demetriades AM; Cai Y; Gao Y; Sui A; Lu Q; Shen X; Jiang C; Xie B; Sun X
    Immunology; 2016 Apr; 147(4):414-28. PubMed ID: 26694999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha.
    Besnard S; Silvestre JS; Duriez M; Bakouche J; Lemaigre-Dubreuil Y; Mariani J; Levy BI; Tedgui A
    Circ Res; 2001 Dec; 89(12):1209-15. PubMed ID: 11739287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide Y
    Eshun D; Saraf R; Bae S; Jeganathan J; Mahmood F; Dilmen S; Ke Q; Lee D; Kang PM; Matyal R
    J Appl Physiol (1985); 2017 Jun; 122(6):1388-1397. PubMed ID: 28302707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse model of angiogenesis.
    Couffinhal T; Silver M; Zheng LP; Kearney M; Witzenbichler B; Isner JM
    Am J Pathol; 1998 Jun; 152(6):1667-79. PubMed ID: 9626071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic angiogenesis by autologous adipose-derived regenerative cells: comparison with bone marrow mononuclear cells.
    Hao C; Shintani S; Shimizu Y; Kondo K; Ishii M; Wu H; Murohara T
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(6):H869-79. PubMed ID: 25063790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor-C derived from CD11b+ cells induces therapeutic improvements in a murine model of hind limb ischemia.
    Kuwahara G; Nishinakamura H; Kojima D; Tashiro T; Kodama S
    J Vasc Surg; 2013 Apr; 57(4):1090-9. PubMed ID: 23219511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization of rat hindlimb ischemia model.
    Long J; Wang S; Zhang Y; Liu X; Zhang H; Wang S
    J Vasc Surg; 2013 Sep; 58(3):756-65.e2. PubMed ID: 23562340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
    Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells.
    Hardy B; Battler A; Weiss C; Kudasi O; Raiter A
    Biochem Pharmacol; 2008 Feb; 75(4):891-9. PubMed ID: 18022603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiangiogenic Effect of Platelet P2Y
    Wang X; Zhao H; Yang N; Jin Y; Chen J
    Biomed Res Int; 2021; 2021():5529431. PubMed ID: 33898623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A vascular endothelial growth factor activating transcription factor increases the endothelial progenitor cells population and induces therapeutic angiogenesis in a type 1 diabetic mouse with hindlimb ischemia.
    Diao Y; Lian L; Guo L; Chen H; Chen Y; Song X; Li Y
    Chin Med J (Engl); 2014; 127(20):3623-9. PubMed ID: 25316240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
    Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
    Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
    Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.